Quantus

NANOCMS financial statements

KRX:247660 · KOSDAQ · Chemicals · sector #12
₩4,495-3.02%Nov 20 close

NANOCMS's published financial data is dated 2026-11-15. 2024 revenue was KRW 4.65B. 2024 operating profit was −KRW 9.17B.

Reported results

Financial safety

Reference indicatorAs of 2024
Distress zoneFinancial-metric reference signal
Altman Z'' zoneZ'' -1.20
Distress
Grey
Safe
The marker shows the current Z'' value within the displayed zones.
Altman Z''
-1.20
Beneish M-Score
-4.44

No statistical flag

Sloan accrual
-28.79%

These are factual indicators of distress and manipulation risk. They are not investment advice and are for reference only, as they have not yet been validated.

Factual information, not investment advice.

Earnings quality · Piotroski F-Score

3/9Weak

Piotroski measures year-over-year financial improvement, not absolute quality.

Financial improvement score3/9

Profitability

  • Positive ROANot passed
  • Positive OCFPass
  • Improving ΔROANot passed
  • Accruals (OCF > net income)Pass

Leverage & liquidity

  • Lower debtNot passed
  • Higher current ratioNot passed
  • No new sharesNot passed

Efficiency

  • Higher gross marginNot passed
  • Higher asset turnoverPass

Calculation note: F7 (new share issuance) is approximated by whether equity/assets was maintained (at least 95% of the prior year).

Already-stable companies may score lower when year-over-year improvement is limited.

Factual information, not investment advice.

Forensic signals

Anomaly and structural signals observed in the financial statements.

Margin trendWarning

영업이익률 악화 (-95.7% → -197.2%, -101.5%p). 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Factual information, not investment advice.

Risk sensitivity — adverse assumptions

Metric changes under stated assumptions; not a forecast or investment advice.

Base metrics

Operating margin
-197.2%
Interest coverage
-11.1x
Return on equity (ROE)
-46%

Operating margin −5pp

Operating loss
Interest coverageBase -11.1x adverse case -11.4x
Return on equity (ROE)Base -46% adverse case -53.2%

Revenue −15%

Interest coverage risk
Interest coverageBase -11.1x adverse case -9.4x
Return on equity (ROE)Base -46% adverse case -44.8%

Interest rate +2pp

Interest coverage risk
Interest coverageBase -11.1x adverse case -8.6x
Return on equity (ROE)Base -46% adverse case -53.2%

Interest coverage limit

Already below the limit by 215pp

Interest coverage limit at an operating margin of 17.7%

Interest expense coverage threshold

NANOCMS:“What if I buy at RSI 30?” 1 free card

NANOCMS notifications

Quantus Signal · live data · not investment advice · Privacy Policy